RESUMO
A group of patients was found to have a special form of recurrent corneal erosion caused by types I and II herpes virus. This form represents an independent form of ophthalmic herpes - herpetic recurrent erosion (HRE) of the cornea. The herpetic etiology of recurrent corneal erosion was confirmed by the immunofluorescence study of scraping from the conjunctiva, which revealed a high concentration of the herpes simplex virus antigen. Treatment of patients (171 patients, 182 eyes) with HRE included 2 consecutive stages: stage I - relief of acute symptoms of the disease with the help of conservative treatment (instillations of interferon inducers, autologous serum, corneal protectors, tear substitutes, use of therapeutic soft contact lenses); in some cases, phototherapeutic keratectomy was used in the absence of the effect of conservative therapy, as well as in the localization of the focus in the optical zone. Stage II involved anti-relapse therapy based on the use of a Russian-produced herpes vaccine in the intercurrent period. After vaccination, observation for 2 years or more showed that 81.3% of patients achieved clinical recovery (complete cessation of HRE recurrences), 15.8% had a decrease in the frequency and severity of relapses, while 2.9% of patients did not respond to the treatment.
Assuntos
Ceratite Herpética , Humanos , Masculino , Feminino , Ceratite Herpética/diagnóstico , Ceratite Herpética/etiologia , Ceratite Herpética/terapia , Ceratite Herpética/prevenção & controle , Pessoa de Meia-Idade , Adulto , Recidiva , Córnea , Resultado do Tratamento , Antivirais/uso terapêutico , Prevenção Secundária/métodos , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/etiologia , Infecções Oculares Virais/prevenção & controle , Infecções Oculares Virais/terapiaRESUMO
PURPOSE: The ongoing coronavirus disease-2019 (COVID-19) pandemic has greatly impacted theworld. In this review article, we discuss the conjunctival and nasolacrimal mucosa as a potential route for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission, its ocular manifestations, and management. METHODS: Literature review was conducted in the PubMed, Google Scholar and EMBASE databases using keywords such as "coronavirus", COVID-19", "SARS-CoV-2", "conjunctivitis", "ocular surface", "eye" and "ophthalmology". RESULTS: The ocular surface may serve as an entry point and reservoir for the virus. Frequency of hand-eye contact was an independent risk factor for COVID-19-related conjunctivitis. Therefore, appropriate protective eyewear or face shields are recommended, especially for health-care workers. Bilateral conjunctival sampling within 9 days of symptom onset provides a higher positive yield rate. Pooled analysis shows an incidence of 11.4% (95%CI = 6.4-17.2%) of ocular manifestations in patients with SARS-CoV-2 infection, including hospitalized and non-hospitalized patients. CONCLUSION: Conjunctivitis was the most common ocular manifestation, of which ocular redness or congestion, ocular pain, and follicular conjunctivitis were the most common presentation.COVID-19-related conjunctivitis has a self-limiting disease course, and treatment should be mainly supportive.
Assuntos
COVID-19 , Conjuntivite , Infecções Oculares Virais , Humanos , COVID-19/epidemiologia , SARS-CoV-2 , Conjuntivite/diagnóstico , Conjuntivite/epidemiologia , Conjuntivite/terapia , Túnica Conjuntiva , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/epidemiologia , Infecções Oculares Virais/terapiaRESUMO
PURPOSE: To evaluate the clinical features, treatment, and visual outcome of patients with acute retinal necrosis (ARN). METHODS: The data of patients were retrospectively reviewed. Factors associated with visual loss and factors affecting the risk for retinal detachment (RD) development were evaluated. RESULTS: Twenty-four eyes of 24 patients (7 female/17 male, mean age 43.7 years, mean follow-up period 31.0 months) were included. In ocular fluid samples of 15 (83%) out of 18 eyes, polymerase chain reaction (PCR) tests were positive for herpes simplex virus (seven eyes; 39%), varicella zoster virus (six eyes; 33%), cytomegalovirus (one eye; 6%), and adenovirus (one eye; 6%). Central retinal occlusive vasculitis was observed in three (13%) eyes. Systemic antiviral therapy was given to all patients, and additional intravitreal ganciclovir was administered in seven eyes (29%). The most common complication was RD (46%). There was no statistically significant difference in the frequency of RD between herpes simplex virus- and varicella zoster virus-positive patients (p = .617). The rate of RD was similar in eyes undergoing prophylactic laser photocoagulation (LPC), eyes undergoing vitrectomy + LPC, and eyes not undergoing LPC (p = .237). The number of eyes with final visual acuity below 20/200 was significantly higher in eyes with RD than without RD (p = .047). CONCLUSION: Prophylactic LPC and vitrectomy did not show clear benefits in terms of preventing RD development. RD was the most common complication and a major factor for a poor visual prognosis.
Assuntos
Infecções Oculares Virais , Descolamento Retiniano , Síndrome de Necrose Retiniana Aguda , Humanos , Masculino , Feminino , Adulto , Síndrome de Necrose Retiniana Aguda/diagnóstico , Síndrome de Necrose Retiniana Aguda/terapia , Estudos Retrospectivos , Antivirais/uso terapêutico , Infecções Oculares Virais/terapia , Infecções Oculares Virais/tratamento farmacológico , Herpesvirus Humano 3 , Vitrectomia/efeitos adversos , Corpo Vítreo , Descolamento Retiniano/cirurgiaRESUMO
ABSTRACT: This brief definitive review of herpes zoster (HZ) will cover the current state of knowledge and questions that remain to be answered regarding HZ in general and HZ ophthalmicus in particular. A question-and-answer format will be used to address various important topics related to this common and serious disease. Questions to be addressed relate to common misconceptions, contagiousness of infection, unknowns regarding pathogenesis, rising incidence, risk factors and complications, relationship with temporal arteritis, vaccination, and current and future antiviral treatment. In addition, the importance of the Zoster Eye Disease Study to determine the efficacy of suppressive valacyclovir treatment in preventing complications of HZ ophthalmicus and the need to support enrollment will be discussed.
Assuntos
Antivirais/uso terapêutico , Infecções Oculares Virais/terapia , Herpes Zoster Oftálmico/terapia , Vacina contra Herpes Zoster/uso terapêutico , Herpes Zoster/genética , RNA Viral/análise , Vacinação/métodos , Infecções Oculares Virais/epidemiologia , Infecções Oculares Virais/virologia , Saúde Global , Herpes Zoster Oftálmico/epidemiologia , Herpes Zoster Oftálmico/virologia , Humanos , IncidênciaRESUMO
Purpose: The objective of this study was to report a case of bilateral necrotizing retinitis following viral encephalitis caused by the pseudorabies virus.Case report: A 49-year-old male had decreased bilateral visual acuity after the recovery of consciousness for one month. He had been in an unconsciousness status due to encephalitis for two months before the ocular symptoms developed. He was a pig slaughterer. Ocular ultrasound showed bilateral vitreous haze and retinal detachment. A vitrectomy and silicone oil tamponade were performed on the left eye. During surgery, massive periphery retinal necrosis appearing as a tattered fish net, and multiple retinal holes were observed. The pseudorabies virus was detected by next-generation sequencing in the vitreous specimen.Conclusion: The pseudorabies virus may cause bilateral necrotizing retinitis following viral encephalitis among those with close contact to pigs. Intraocular fluid provides a greater selection of samples and a longer time window for pathogenic detection.
Assuntos
Encefalite Viral/virologia , Infecções Oculares Virais/virologia , Herpesvirus Suídeo 1/isolamento & purificação , Pseudorraiva/virologia , Síndrome de Necrose Retiniana Aguda/virologia , Doenças dos Suínos/virologia , Zoonoses/transmissão , Animais , Encefalite Viral/diagnóstico , Encefalite Viral/terapia , Tamponamento Interno , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/terapia , Genoma Viral/genética , Herpesvirus Suídeo 1/genética , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Masculino , Pessoa de Meia-Idade , Pseudorraiva/diagnóstico , Descolamento Retiniano/diagnóstico , Descolamento Retiniano/terapia , Descolamento Retiniano/virologia , Síndrome de Necrose Retiniana Aguda/diagnóstico , Síndrome de Necrose Retiniana Aguda/terapia , Óleos de Silicone/administração & dosagem , Suínos , Doenças dos Suínos/transmissão , Acuidade Visual/fisiologia , Vitrectomia , Corpo Vítreo/virologia , Zoonoses/virologiaRESUMO
The COVID-19 pandemic has had an unprecedented impact on ophthalmology. This review compiles general aspects of the novel coronavirus and COVID-19, further dissects the most recent data on the role of the eye regarding disease transmission and manifestations, and summarizes preventive measures in the particular context of eye care.
Assuntos
COVID-19/epidemiologia , Oftalmologistas , SARS-CoV-2 , COVID-19/diagnóstico , COVID-19/terapia , COVID-19/virologia , Educação Médica Continuada , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/epidemiologia , Infecções Oculares Virais/terapia , Infecções Oculares Virais/virologia , Humanos , Pneumonia Viral/diagnóstico , Pneumonia Viral/epidemiologia , Pneumonia Viral/terapia , Pneumonia Viral/virologia , Infecções Respiratórias/diagnóstico , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/terapia , Infecções Respiratórias/virologiaRESUMO
Herpes simplex keratitis, caused primarily by human herpes simplex virus type 1 (HSV-1), remains the most common infectious cause of unilateral blindness and vision impairment in the industrialized world. Major advances in the care of HSV keratitis have been driven in large part by the landmark Herpetic Eye Disease Study randomized clinical trials, which were among the first in ophthalmology to reflect emerging trial conventions, including multicenter subject enrollment, double-masking, placebo controls, and a priori sample size determinations. The results of these trials now form much of the evidence basis for the management of this disease. However, management patterns in clinical practice often deviate from evidence-based care. These perceived quality gaps have given rise to the evolving field of implementation science, which is concerned with the methods of promoting the application of evidence-based medicine within routine care. To overcome variations in the quality and consistency of care for HSV keratitis, a range of clinical- and technology-based innovations are proposed. The most pressing needs include the following: a rational and tractable disease classification scheme that provides an immediate link between the anatomical localization of disease (corneal epithelial, stromal, or endothelial) and the appropriate treatment, and the actualization of an electronic medical record system capable of providing evidence-based treatment algorithms at relevant points of care. The latter would also input data to population-wide disease registries to identify implementation-rich targets for quality improvement, education, and research. These innovations may allow us to reduce the human and economic burdens of this highly morbid, and often blinding, disease.
Assuntos
Doenças da Córnea/terapia , Infecções Oculares Virais/terapia , Ceratite Herpética/terapia , Terapias em Estudo , Antivirais/uso terapêutico , Doenças da Córnea/classificação , Doenças da Córnea/epidemiologia , Medicina Baseada em Evidências , Infecções Oculares Virais/classificação , Infecções Oculares Virais/epidemiologia , Glucocorticoides/uso terapêutico , Humanos , Ceratite Herpética/classificação , Ceratite Herpética/epidemiologiaRESUMO
PURPOSE: To develop and measure the uptake of a local guideline for herpes simplex keratitis (HSK) and to standardize initial antiviral therapy in Australia. METHODS: The Registered Nurses' Association of Ontario Toolkit: "Implementation of Best Practice Guidelines" was used to develop, implement, and evaluate the guideline at Sydney Eye Hospital. An implementation team was established to reach consensus on antiviral therapy guidelines through review of available evidence, identifying stakeholders, facilitators and barriers, creating strategies for implementation, and developing a sustainability plan. An audit of all adult HSK cases during a 6-month postguideline implementation period was conducted, and the results were compared with a preimplementation audit. A web-based survey was created to assess clinician awareness, usage, and level of knowledge of the guideline. RESULTS: Clinicians, pharmacists, and administrative staff were identified as stakeholders. Changing clinician's behavior was the major barrier to implementation. Implementation strategies included printed and online materials and lectures to clinicians. A postimplementation audit included 85 patients, and 95 clinicians received a web-based survey. The dose of the prescribed antiviral medication was in alignment with the local guideline in 80% (51/64) of the patients compared with 73% (163/223) before implementation (P = 0.331). Stromal HSK with ulceration and keratouveitis were excluded because there were no recommendations before implementation. Over 70% of clinicians (30/41) were aware of the guideline and accessed them through educational resources. CONCLUSIONS: Guidelines for the management of HSK may improve standardization of initial antiviral therapy in HSK. In practice, most clinicians were aware of and adhered to the local guideline.
Assuntos
Gerenciamento Clínico , Infecções Oculares Virais/terapia , Ceratite Herpética/terapia , Guias de Prática Clínica como Assunto , Humanos , New South WalesRESUMO
AIMS: Cases of infectious uveitis in immunodeficient patients may present with atypical clinical features because the clinical course of disease is usually affected by the compromised immune system. Therefore, it is sometimes difficult to determine the correct diagnosis. The aim of this study was to evaluate a prevalence of immunodeficient HIV-negative individuals among patients with infectious uveitis and to assess diagnostic and therapeutic approaches. METHODS: A retrospective study. RESULTS: In years 2003-2017, we diagnosed 594 patients with infectious uveitis. In 35 of them, infectious uveitis occurred on the basis of immunodeficiency (malignancy, immunosuppressive therapy etc.). The most common infectious uveitis was cytomegalovirus retinitis, followed by acute retinal necrosis, herpetic anterior uveitis, endogenous fungal endophthalmitis, toxoplasmic retinochoroiditis, progressive outer retinal necrosis and syphilis. In indicated cases, intraocular fluid examination was a valuable diagnostic tool. After initiation of treatment, improvement of BCVA was observed in 13 eyes, stabilization in 13 eyes and deterioration in 11 eyes. In some patients who experienced adverse effects of medication, the recommended doses were decreased. CONCLUSION: Our experience shows that patients with diagnoses of acute retinal necrosis or progressive outer retinal necrosis have a poor visual prognosis. The occurrence of cytomegalovirus retinitis signifies a very unfavorable survival prognosis in patients who underwent hematopoietic stem cell transplantation; the patients in our study died within 1 year from cytomegalovirus retinitis diagnosis.
Assuntos
Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/etiologia , Infecções Oculares Virais/terapia , Hospedeiro Imunocomprometido , Uveíte/diagnóstico , Uveíte/etiologia , Uveíte/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , República Tcheca , Infecções Oculares Virais/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Uveíte/fisiopatologia , Adulto JovemAssuntos
Antivirais/uso terapêutico , Infecções Oculares Virais/terapia , Glucocorticoides/uso terapêutico , Terapia a Laser , Síndrome de Necrose Retiniana Aguda/terapia , Infecção pelo Vírus da Varicela-Zoster/terapia , Vitrectomia , DNA Viral/genética , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/virologia , Herpes Simples/genética , Herpesvirus Humano 3/genética , Humanos , Reação em Cadeia da Polimerase , Síndrome de Necrose Retiniana Aguda/diagnóstico , Síndrome de Necrose Retiniana Aguda/virologia , Infecção pelo Vírus da Varicela-Zoster/diagnóstico , Infecção pelo Vírus da Varicela-Zoster/virologiaAssuntos
Retinite por Citomegalovirus/etiologia , Citomegalovirus , Infecções Oculares Virais/etiologia , Leucemia Mieloide Aguda/complicações , Doenças do Nervo Óptico/etiologia , Descolamento Retiniano/etiologia , Viremia/complicações , Antivirais/administração & dosagem , Transplante de Medula Óssea/efeitos adversos , Criança , Retinite por Citomegalovirus/diagnóstico , Retinite por Citomegalovirus/terapia , Infecções Oculares Virais/terapia , Infecções Oculares Virais/virologia , Fundo de Olho , Ganciclovir/administração & dosagem , Humanos , Injeções Intravítreas , Leucemia Mieloide Aguda/terapia , Masculino , Atrofia Óptica , Doenças do Nervo Óptico/diagnóstico , Doenças do Nervo Óptico/terapia , Doenças do Nervo Óptico/virologia , Descolamento Retiniano/diagnóstico , Descolamento Retiniano/terapia , Tomografia de Coerência Óptica , Viremia/terapia , Viremia/virologia , Acuidade Visual/fisiologia , VitrectomiaRESUMO
PURPOSE OF REVIEW: Adenoviral keratitis is a common and bothersome ocular infection that produces a lot of burden on healthcare systems and patients. The goal of this article is to provide a review of the topic, with an emphasis on current attempts at advancing strategies in diagnosis and management. RECENT FINDINGS: Sixty-eight articles and one textbook published on adenoviral keratitis were reviewed. The findings on the epidemiology, pathophysiology, clinical features, diagnosis, and management were summarized. Any contradicting opinions for which the literature was unclear were either omitted or recorded as lacking strong evidence. SUMMARY: Although significant effort has been made to develop new methods for diagnosis and management, adenoviral keratitis is predominantly diagnosed clinically with prevention being the mainstay of management. The use of newer DNA analysis techniques and topical anti-inflammatory agents for treatment of corneal infiltrates show promising results, but a better understanding of the pathogenesis and clinical features can lead to more targeted methods of diagnosis and therapy.
Assuntos
Adenoviridae/patogenicidade , Infecções por Adenovirus Humanos , Infecções Oculares Virais , Ceratite , Infecções por Adenovirus Humanos/diagnóstico , Infecções por Adenovirus Humanos/epidemiologia , Infecções por Adenovirus Humanos/fisiopatologia , Infecções por Adenovirus Humanos/terapia , Administração Tópica , Anti-Inflamatórios/uso terapêutico , Antivirais/uso terapêutico , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/epidemiologia , Infecções Oculares Virais/fisiopatologia , Infecções Oculares Virais/terapia , Humanos , Ceratite/diagnóstico , Ceratite/epidemiologia , Ceratite/fisiopatologia , Ceratite/terapiaRESUMO
Adenoviral conjunctivitis comprises a large number of physician office visits in the United States and places a great financial burden on health care. It is estimated that the incidence of adenovirus infection to be as high as 20 million cases per year in the United States. There are multiple adenovirus serotypes, each associated with different types and severity of infection. Ocular manifestations of adenovirus include epidemic keratoconjunctivitis, pharyngoconjunctival fever, and nonspecific conjunctivitis. Adenoviral conjunctivitis is primarily a clinical diagnosis. Laboratory diagnosis is available although until recently rarely used. At present, there is no established or approved specific effective drug against adenovirus. Treatment is primarily supportive and includes artificial tears and cool compresses. Topical antibiotics are only indicated if a bacterial coinfection is suspected or in high-risk patients such as children. Prevention against this extremely contagious disease is of utmost importance. Although most cases are self-limited and have a relatively benign course, permanent visual disability can occur. For this reason, it is imperative that all eye care providers are capable of diagnosing and effectively treating these patients, and also preventing the spread of this contagious disease to others.
Assuntos
Infecções por Adenoviridae , Infecções Oculares Virais/virologia , Adenoviridae , Infecções por Adenoviridae/epidemiologia , Infecções por Adenoviridae/patologia , Infecções por Adenoviridae/terapia , Infecções Oculares Virais/epidemiologia , Infecções Oculares Virais/terapia , Humanos , Incidência , Prevalência , Estados Unidos/epidemiologiaRESUMO
BACKGROUND/AIMS: To investigate the efficacy of topical ganciclovir (GCV) for preventing disease recurrence and improving the surgical outcome post-Descemet's stripping automated endothelial keratoplasty (DSAEK) in patients with cytomegalovirus (CMV) endotheliitis. METHODS: This prospective, non-comparative case series study involved six eyes of six patients with endothelial decompensation due to CMV endotheliitis who underwent DSAEK, followed by a continuous, four to six times daily, topical administration of 0.5% GCV. Patient demographics, clinical history, and preoperative and postoperative examination (including any recurrence of CMV endotheliitis post-DSAEK), best corrected visual acuity (BCVA), intraocular pressure (IOP), graft survival rate and endothelial cell density (ECD) were examined. RESULTS: No recurrence of CMV endotheliitis was detected post-DSAEK. The mean follow-up period was 40 months (range, 12-60 months). The mean preoperative BCVA was 1.52±0.68 LogMAR (range, 0.52-2.40 LogMAR), yet it had significantly improved to 0.15±0.16 LogMAR (range: -0.08 to 0.30 LogMAR) by 1 year postoperative (P<0.01). In all patients, IOP was well controlled (10-20 mm Hg) postsurgery. The mean preoperative donor ECD was 2692±177 cells/mm2, and the mean postoperative ECD was 1974, 1771 and 1174 cells/mm2 for the ECD loss of 26%, 33% and 54% at 6, 12 and 36 months, respectively. No adverse effects were observed associated with the long-term topical administration of GCV. CONCLUSION: The continuous topical application of 0.5% GCV was found to be effective for preventing the recurrence of CMV endotheliitis, and it provided the optimal mid-term clinical outcomes post-DSAEK in patients with CMV endotheliitis. TRIAL REGISTRATION NUMBER: UMIN000026746.
Assuntos
Doenças da Córnea/terapia , Infecções por Citomegalovirus/terapia , Ceratoplastia Endotelial com Remoção da Lâmina Limitante Posterior , Infecções Oculares Virais/terapia , Ganciclovir/administração & dosagem , Administração Tópica , Adulto , Idoso , Idoso de 80 Anos ou mais , Antivirais/administração & dosagem , Doenças da Córnea/virologia , Citomegalovirus/genética , Infecções por Citomegalovirus/virologia , DNA Viral/análise , Infecções Oculares Virais/virologia , Feminino , Seguimentos , Sobrevivência de Enxerto , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de TempoRESUMO
Zika virus (ZIKV) disease outbreak, which was declared by the end of 2015 in Brazil, has become the largest one to date. Being reported in the Americas and in certain islands of the Pacific, it has the potential to spread worldwide. Although ZIKV infections are mostly self-limiting and/or asymptomatic in the healthy adult, they are responsible for devastating congenital neurologic malformations ZIKV (mainly microcephaly) when contracted during the first months of pregnancy. Ocular manifestations during the acute adult infection include conjunctivitis and more rarely ocular inflammation. Congenital infection is associated with chorioretinal atrophy pigment mottling of the retina retinal vasculature abnormalities and optic nerve atrophy. Therefore, complete ophthalmological evaluation is recommended for suspected congenital infections.
Assuntos
Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/terapia , Infecção por Zika virus/diagnóstico , Infecção por Zika virus/terapia , Brasil/epidemiologia , Surtos de Doenças , Epidemias , Infecções Oculares Virais/congênito , Infecções Oculares Virais/epidemiologia , Feminino , Humanos , Recém-Nascido , Doenças do Recém-Nascido/diagnóstico , Doenças do Recém-Nascido/epidemiologia , Doenças do Recém-Nascido/terapia , Transmissão Vertical de Doenças Infecciosas/estatística & dados numéricos , Triagem Neonatal/métodos , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/terapia , Infecção por Zika virus/congênito , Infecção por Zika virus/epidemiologiaRESUMO
Purpose: To determine cellular and temporal expression patterns of herpes virus entry mediator (HVEM, Tnfrsf14) in the murine cornea during the course of herpes simplex virus 1 (HSV-1) infection, the impact of this expression on pathogenesis, and whether alterations in HVEM or downstream HVEM-mediated effects ameliorate corneal disease. Methods: Corneal HVEM levels were assessed in C57BL/6 mice after infection with HSV-1(17). Leukocytic infiltrates and corneal sensitivity loss were measured in the presence, global absence (HVEM knockout [KO] mice; Tnfrsf14-/-), or partial absence of HVEM (HVEM conditional KO). Effects of immune-modifying nanoparticles (IMPs) on viral replication, corneal sensitivity, and corneal infiltrates were measured. Results: Corneal HVEM+ populations, particularly monocytes/macrophages during acute infection (3 days post infection [dpi]) and polymorphonuclear neutrophils (PMN) during the chronic inflammatory phase (14 dpi), increased after HSV-1 infection. Herpes virus entry mediator increased leukocytes in the cornea and corneal sensitivity loss. Ablation of HVEM from CD45+ cells, or intravenous IMP therapy, reduced infiltrates in the chronic phase and maintained corneal sensitivity. Conclusions: Herpes virus entry mediator was expressed on two key populations: corneal monocytes/macrophages and PMNs. Herpes virus entry mediator promoted the recruitment of myeloid cells to the cornea in the chronic phase. Herpes virus entry mediator-associated corneal sensitivity loss preceded leukocytic infiltration, suggesting it may play an active role in recruitment. We propose that HVEM on resident corneal macrophages increases nerve damage and immune cell invasion, and we showed that prevention of late-phase infiltration of PMN and CD4+ T cells by IMP therapy improved clinical symptoms and mortality and reduced corneal sensitivity loss caused by HSV-1.
Assuntos
Infecções Oculares Virais/terapia , Infecções por Herpesviridae/terapia , Herpesvirus Humano 1/patogenicidade , Imunoterapia/métodos , Ceratite Herpética/terapia , Ácido Láctico/administração & dosagem , Ácido Poliglicólico/administração & dosagem , Membro 14 de Receptores do Fator de Necrose Tumoral/administração & dosagem , Animais , Materiais Biocompatíveis/administração & dosagem , Córnea/metabolismo , Córnea/patologia , Córnea/virologia , Modelos Animais de Doenças , Infecções Oculares Virais/diagnóstico , Infecções Oculares Virais/imunologia , Citometria de Fluxo , Infecções por Herpesviridae/diagnóstico , Infecções por Herpesviridae/imunologia , Imunidade Celular , Imuno-Histoquímica , Injeções Intravenosas , Ceratite Herpética/diagnóstico , Ceratite Herpética/imunologia , Ceratite Herpética/virologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Nanopartículas , Copolímero de Ácido Poliláctico e Ácido PoliglicólicoRESUMO
PURPOSE: To evaluate the available evidence in peer-reviewed publications about the diagnosis and treatment of acute retinal necrosis (ARN). METHODS: Literature searches of the PubMed and Cochrane Library databases were last conducted on July 27, 2016. The searches identified 216 unique citations, and 49 articles of possible clinical relevance were reviewed in full text. Of these 49 articles, 27 were deemed sufficiently relevant or of interest, and they were rated according to strength of evidence. An additional 6 articles were identified from the reference lists of these articles and included. All 33 studies were retrospective. RESULTS: Polymerase chain reaction (PCR) testing of aqueous or vitreous humor was positive for herpes simplex virus (HSV) or varicella zoster virus (VZV) in 79% to 100% of cases of suspected ARN. Aqueous and vitreous specimens are both sensitive and specific. There is level II and III evidence supporting the use of intravenous and oral antiviral therapy for the treatment of ARN. Data suggest that equivalent plasma drug levels of acyclovir can be achieved after administration of oral valacyclovir or intravenous acyclovir. There is level II and III evidence suggesting that the combination of intravitreal foscarnet and systemic antiviral therapy may have greater therapeutic efficacy than systemic therapy alone. The effectiveness of prophylactic laser or early pars plana vitrectomy (PPV) in preventing retinal detachment (RD) remains unclear. CONCLUSIONS: Polymerase chain reaction testing of ocular fluid is useful in supporting a clinical diagnosis of ARN, but treatment should not be delayed while awaiting PCR results. Initial oral or intravenous antiviral therapy is effective in treating ARN. The adjunctive use of intravitreal foscarnet may be more effective than systemic therapy alone. The role of prophylactic laser retinopexy or early PPV is unknown at this time.